Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review

Figure 1

Baseline characteristics and medication use and clinical outcomes in patients with CAD and PAD from the REACH Registries of (a) Canada, (b) France, and (c) Germany [1, 2]. Patients enrolled from January to October 2004; mean age 68.4 ± 9.9. Percentage of patients experiencing at least one CV event (Figure (a): CAD n = 1356, PAD n = 146; Figure (b): CAD = 2397, PAD = 882; Figure (c): CAD = 3328, PAD = 1303). Patients enrolled from December 2003 to June 2014; mean age 69.1–71.7 across risk groups. Patients enrolled from December 2003 to June 2014; mean age 68.0–69.4 across risk groups. ACE, angiotensin-converting enzyme; ASA, acetylsalicylic acid; CAD, coronary artery disease; CV, cardiovascular; PAD, peripheral artery disease.

(a) REACH registry of Canada

(b) REACH registry of France

(c) REACH registry of Germany